Clinical Laboratory, University Hospital Virgen de la Victoria, Málaga, Spain.
Clin Chem Lab Med. 2009;47(12):1549-52. doi: 10.1515/CCLM.2009.338.
Preanalytical mistakes (PAMs) in samples usually led to rejection upon arrival to the clinical laboratory. However, PAMs might not always be detected and result in clinical problems. Thus, PAMs should be minimized. We detected PAMs in samples from Primary Health Care Centres (PHCC) served by our central laboratory. Thus, the goal of this study was to describe the number and types of PAMs, and to suggest some strategies for improvement.
The presence of PAMs, as sample rejection criteria, in samples submitted from PHCC to our laboratory during October and November 2007 was retrospectively analysed.
Overall, 3885 PAMs (7.4%) were detected from 52,669 samples for blood analyses. This included missed samples (n=1763; 45.4% of all PAMs, 3.3% of all samples), haemolysed samples (n=1408; 36.2% and 2.7%, respectively), coagulated samples (n=391; 10% and 0.7%, respectively), incorrect sample volume (n=110; 2.8% and 0.2%, respectively), and others (n=213; 5.5% and 0.4%, respectively). For urine samples (n=18,852), 1567 of the samples were missing (8.3%).
We found the proportion of PAMs in blood and urine samples to be 3-fold higher than that reported in the literature. Therefore, strategies for improvement directed towards the staff involved, as well as an exhaustive audit of preanalytical process are needed. To attain this goal, we first implemented a continued education programme, financed by our Regional Health Service and focused in Primary Care Nurses.
样本的分析前错误(PAMs)通常会导致样本在到达临床实验室时被拒收。然而,PAMs 并不总是能够被检测到,从而导致临床问题。因此,应尽量减少 PAMs 的发生。我们检测了由我们的中心实验室服务的基层医疗保健中心(PHCC)送来的样本中的 PAMs。因此,本研究的目的是描述 PAMs 的数量和类型,并提出一些改进策略。
回顾性分析了 2007 年 10 月和 11 月期间,从 PHCC 送到我们实验室的样本中 PAMs 作为样本拒收标准的存在情况。
总体而言,在 52669 个血液分析样本中发现了 3885 个 PAMs(7.4%)。这包括漏检样本(n=1763;占所有 PAMs 的 45.4%,所有样本的 3.3%)、溶血样本(n=1408;占所有 PAMs 的 36.2%,占所有样本的 2.7%)、凝固样本(n=391;占所有 PAMs 的 10%,占所有样本的 0.7%)、样本量不正确(n=110;占所有 PAMs 的 2.8%,占所有样本的 0.2%)和其他(n=213;占所有 PAMs 的 5.5%,占所有样本的 0.4%)。对于尿液样本(n=18852),有 1567 个样本缺失(8.3%)。
我们发现血液和尿液样本中的 PAMs 比例是文献报道的 3 倍。因此,需要针对相关人员制定改进策略,并对分析前过程进行全面审核。为了实现这一目标,我们首先实施了一项由我们的区域卫生服务机构资助的、专注于初级保健护士的持续教育培训计划。